<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37654150</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1000-503X</ISSN><JournalIssue CitedMedium="Print"><Volume>45</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae</Title><ISOAbbreviation>Zhongguo Yi Xue Ke Xue Yuan Xue Bao</ISOAbbreviation></Journal><ArticleTitle>[Advances in the Role of Low-Dose Interleukin-2 in Immune-Mediated Dermatosis].</ArticleTitle><Pagination><StartPage>683</StartPage><EndPage>688</EndPage><MedlinePgn>683-688</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3881/j.issn.1000-503X.15198</ELocationID><Abstract><AbstractText>Immune-mediated dermatoses are the skin diseases caused by the breakdown of immune tolerance,including lupus erythematosus and dermatomyositis.The imbalance between regulatory T cells (Tregs) and effector T cells (Teffs) plays a key role in the pathogenesis of these diseases.Low-dose interleukin-2 can preferentially activate Tregs and reverse the imbalance between Tregs and Teffs to recover the immune tolerance,which has attracted attention in the treatment of immune-mediated dermatoses.This review summarizes the research progress in the immunomodulatory mechanism and clinical application of low-dose interleukin-2 in immune-mediated dermatoses,providing a new idea for the clinical treatment of these diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qiao</LastName><ForeName>Zu-Sha</ForeName><Initials>ZS</Initials><AffiliationInfo><Affiliation>Department of Dermatology,Second Hospital of Shanxi Medical University,Taiyuan 030001,China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Hong-Zhong</ForeName><Initials>HZ</Initials><AffiliationInfo><Affiliation>Department of Dermatology,PUMC Hospital,CAMS and PUMC,Beijing 100730,China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhongguo Yi Xue Ke Xue Yuan Xue Bao</MedlineTA><NlmUniqueID>8006230</NlmUniqueID><ISSNLinking>1000-503X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007376">Interleukin-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007376" MajorTopicYN="N">Interleukin-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050378" MajorTopicYN="N">T-Lymphocytes, Regulatory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012871" MajorTopicYN="Y">Skin Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText>&#x514d;&#x75ab;&#x76f8;&#x5173;&#x6027;&#x76ae;&#x80a4;&#x75c5;&#x662f;&#x4e00;&#x7c7b;&#x56e0;&#x81ea;&#x8eab;&#x514d;&#x75ab;&#x8010;&#x53d7;&#x7834;&#x574f;&#x5bfc;&#x81f4;&#x7684;&#x76ae;&#x80a4;&#x75c5;,&#x5305;&#x62ec;&#x7ea2;&#x6591;&#x72fc;&#x75ae;&#x3001;&#x76ae;&#x808c;&#x708e;&#x7b49;&#x3002;&#x8c03;&#x8282;&#x6027;T&#x7ec6;&#x80de;&#x4e0e;&#x6548;&#x5e94;&#x6027;T&#x7ec6;&#x80de;&#x4e4b;&#x95f4;&#x5931;&#x8861;&#x5728;&#x514d;&#x75ab;&#x76f8;&#x5173;&#x6027;&#x76ae;&#x80a4;&#x75c5;&#x53d1;&#x75c5;&#x673a;&#x5236;&#x4e2d;&#x8d77;&#x91cd;&#x8981;&#x4f5c;&#x7528;&#x3002;&#x4f4e;&#x5242;&#x91cf;&#x767d;&#x7ec6;&#x80de;&#x4ecb;&#x7d20;-2&#x53ef;&#x4f18;&#x5148;&#x6fc0;&#x6d3b;&#x8c03;&#x8282;&#x6027;T&#x7ec6;&#x80de;,&#x9006;&#x8f6c;&#x8c03;&#x8282;&#x6027;T&#x7ec6;&#x80de;&#x4e0e;&#x6548;&#x5e94;&#x6027;T&#x7ec6;&#x80de;&#x5931;&#x8861;,&#x6062;&#x590d;&#x514d;&#x75ab;&#x8010;&#x53d7;,&#x5728;&#x514d;&#x75ab;&#x76f8;&#x5173;&#x6027;&#x76ae;&#x80a4;&#x75c5;&#x7684;&#x6cbb;&#x7597;&#x9886;&#x57df;&#x4e2d;&#x9010;&#x6e10;&#x53d7;&#x5230;&#x5173;&#x6ce8;&#x3002;&#x672c;&#x6587;&#x7efc;&#x8ff0;&#x4e86;&#x4f4e;&#x5242;&#x91cf;&#x767d;&#x7ec6;&#x80de;&#x4ecb;&#x7d20;-2&#x7684;&#x514d;&#x75ab;&#x8c03;&#x63a7;&#x673a;&#x5236;&#x53ca;&#x4e34;&#x5e8a;&#x7814;&#x7a76;&#x8fdb;&#x5c55;,&#x4e3a;&#x514d;&#x75ab;&#x76f8;&#x5173;&#x6027;&#x76ae;&#x80a4;&#x75c5;&#x7684;&#x6cbb;&#x7597;&#x63d0;&#x4f9b;&#x65b0;&#x7684;&#x601d;&#x8def;&#x3002;.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">effector T cell</Keyword><Keyword MajorTopicYN="N">immune-mediated dermatosis</Keyword><Keyword MajorTopicYN="N">interleukin-2</Keyword><Keyword MajorTopicYN="N">regulatory T cell</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>3</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37654150</ArticleId><ArticleId IdType="doi">10.3881/j.issn.1000-503X.15198</ArticleId><ArticleId IdType="pii">1693547421501-1397579615</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>